Monday, February 16, 2026 2/16/2026

Synaptic mechanisms of tau-mediated pathogenesis in human iPSC-derived neurons

Award Number: K01AG057862
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 04/15/2018
PERIOD OF PERFORMANCE END DATE: 02/28/2023

Group Awards By:

View Award Description

Synaptic mechanisms of tau-mediated pathogenesis in human iPSC-derived neurons - PROJECT SUMMARY/ABSTRACT Tauopathies are currently the most prevalent neurodegenerative diseases in our country and represent a public health crisis for our rapidly aging demographic. People living with tauopathy, including Alzheimer's disease (AD) and frontotemporal lobar degeneration with tau inclusions (FTLD-tau), are afflicted with severe and devastating memory loss. There are few treatments available for people suffering from cognitive decline and there is no cure. Memory impairments in AD are highly correlated with synapse loss in the brain, suggesting that synaptic function is particularly vulnerable and may be the most promising target for a successful therapeutic outcome. However, the pathogenic events that lead to synapse decline in tauopathy are not well understood. The accumulation of tau, a microtubule-associated protein, in the brain is a hallmark of tauopathy that coincides with progressive neurodegeneration. How tau contributes to synaptic decline is unclear. The main objectives of the proposed research are to determine how tau affects synaptic function in human induced pluripotent stem cell (iPSC)- derived neurons and to identify tau-dependent mechanisms that modulate synapses. This research will apply cutting-edge techniques including targeted genome editing of iPSCs and NGN2-induced iPSC differentiation into neurons. CRISPR-based genome editing of tauopathy patient derived iPSCs with FTLD-tau mutations will generate isogenic iPSCs with corrected mutations. A wild-type tau iPSC line will also be genetically modified using CRISPR to generate isogenic iPSCs carrying mutations that cause familial FTLD-tau. These iPSC lines will be used to determine how tau affects synaptic function in human neuronal models of FTLD-tau (Aim 1). APEX2-based proximity-dependent biotin labeling and quantitative mass spectrometry analyses will be used to identify tau-dependent mechanisms that promote synaptic dysfunction (Aim 2). Finally, tauopathy patient iPSC- derived neurons will be transplanted into mouse brain to determine how tau alters excitatory and inhibitory synaptic transmission in vivo (Aim 3). Further scientific training will enable the candidate to delineate mechanisms linking pathogenic tau and synaptic toxicity in a human disease model. A team of co-mentors and advisory committee members will provide guidance and support for the candidate's research proposal and career advancement. The vibrant scientific community and abundant resources at the Gladstone Institutes and the University of California, San Francisco will enhance the candidate's training. The short-term goals of the candidate are to 1) acquire additional techniques to investigate tauopathy using human neuronal models 2) acquire leadership, mentoring and networking skills for career advancement 3) obtain funding for research as a junior investigator. The long-term goals of the candidate are to make major contributions in tauopathy research by uncovering how tau triggers pathogenic events that lead to neuronal dysfunction and to establish novel strategies for recovering synaptic function in the brain to treat cognitive decline.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = -$32,600 )
2024	2022	BUCK INSTITUTE FOR RESEARCH ON AGING	8001 REDWOOD BLVD	NOVATO	CA	94945	MARIN	USA	Aging Research	000	5	12/4/2023	NON-COMPETING CONTINUATION	-$32,600
														Subtotal = -$32,600

Issue Date FY: 2022 ( Subtotal = $125,289 )
2022	2022	BUCK INSTITUTE FOR RESEARCH ON AGING	8001 REDWOOD BLVD	NOVATO	CA	94945	MARIN	USA	Aging Research	000	5	2/16/2022	NON-COMPETING CONTINUATION	$125,289
														Subtotal = $125,289

Issue Date FY: 2021 ( Subtotal = $124,389 )
2021	2021	BUCK INSTITUTE FOR RESEARCH ON AGING	8001 REDWOOD BLVD	NOVATO	CA	94945	MARIN	USA	Aging Research	000	4	2/19/2021	NON-COMPETING CONTINUATION	$124,389
														Subtotal = $124,389

Issue Date FY: 2020 ( Subtotal = $124,389 )
2020	2020	BUCK INSTITUTE FOR RESEARCH ON AGING	8001 REDWOOD BLVD	NOVATO	CA	94945	MARIN	USA	Aging Research	000	3	1/31/2020	NON-COMPETING CONTINUATION	$124,389
														Subtotal = $124,389

Issue Date FY: 2019 ( Subtotal = $124,389 )
2019	2019	BUCK INSTITUTE FOR RESEARCH ON AGING	8001 REDWOOD BLVD	NOVATO	CA	94945	MARIN	USA	Aging Research	003	2	4/10/2019	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$84,564
2019	2019	BUCK INSTITUTE FOR RESEARCH ON AGING	8001 REDWOOD BLVD	NOVATO	CA	94945	MARIN	USA	Aging Research	001	2	2/4/2019	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$124,389
2019	2018	J.DAVID GLADSTONE INSTITUTES	1650 OWENS ST	SAN FRANCISCO	CA	94158	SAN FRANCISCO	USA	Aging Research	000	1	1/31/2019	NEW	$0
2019	2018	J.DAVID GLADSTONE INSTITUTES	1650 OWENS ST	SAN FRANCISCO	CA	94158	SAN FRANCISCO	USA	Aging Research	002	1	4/10/2019	NEW	-$84,564
														Subtotal = $124,389

Issue Date FY: 2018 ( Subtotal = $128,034 )
2018	2018	J.DAVID GLADSTONE INSTITUTES	1650 OWENS ST	SAN FRANCISCO	CA	94158	SAN FRANCISCO	USA	Aging Research	000	1	4/9/2018	NEW	$128,034
														Subtotal = $128,034

Grand Total All Awards = $593,890

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Synaptic mechanisms of tau-mediated pathogenesis in human iPSC-derived neurons

Award Number: K01AG057862

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 04/15/2018

PERIOD OF PERFORMANCE END DATE: 02/28/2023

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer